The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kapkanets D.V.

N.I. Pirogov Russian National Research Medical University (Pirogov University)

Boyko A.N.

N.I. Pirogov Russian National Research Medical University (Pirogov University);
Federal Center for Brain and Neurotechnologies of the Federal Medical Biological Agency of Russia

Dolgushin M.B.

Federal Center for Brain and Neurotechnologies of the Federal Medical Biological Agency of Russia

Nikitin D.V.

Federal Center for Brain and Neurotechnologies of the Federal Medical Biological Agency of Russia

Nadelaev R.V.

Federal Center for Brain and Neurotechnologies of the Federal Medical Biological Agency of Russia

Change in the volume of choroidal plexus at the onset of a demyelinating disease

Authors:

Kapkanets D.V., Boyko A.N., Dolgushin M.B., Nikitin D.V., Nadelaev R.V.

More about the authors

Read: 625 times


To cite this article:

Kapkanets DV, Boyko AN, Dolgushin MB, Nikitin DV, Nadelaev RV. Change in the volume of choroidal plexus at the onset of a demyelinating disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(7‑2):94‑99. (In Russ.)
https://doi.org/10.17116/jnevro202512507294

Recommended articles:
Mole­cular mechanisms of acute disseminated ence­phalomyelitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):7-11
The role of mono­cytes in the immu­nopathogenesis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):23-27
Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple scle­rosis). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):34-38
Features of the clinical course of multiple scle­rosis as a factor in persistent disa­bility. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):39-44
Quantitative analysis of cere­brospinal fluid flow in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):45-50
Resu­lts of 4 years of therapy with divo­zilimab in patients with rela­psing multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):51-59

References:

  1. Haki M, Al-Biati HA, Al-Tameemi ZS, et al. Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment. Medicine (Baltimore). 2024;103(8):e37297. https://doi.org/10.1097/MD.0000000000037297
  2. Svetlichnaya AV. Epidemiological Characteristics of Inflammatory Demyelinating Diseases of the Central Nervous System Including Multiple Sclerosis. Epidemiologiya i Vaktsinoprofilaktika. 2024;23(1):21-32. (In Russ.). https://doi.org/10.31631/2073-3046-2024-23-1-21-32
  3. Liu R, Du S, Zhao L, et al. Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target. Front Immunol. 2022;13:996469. https://doi.org/10.3389/fimmu.2022.996469
  4. Bryukhov VV, Popova EV, Krotenkova MV, et al. Radiologically isolated syndrome — MRI criteria and management tactic. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(10):47-52. (In Russ.). https://doi.org/10.17116/jnevro201611610247-52
  5. Okuda DT, Siva A, Kantarci O, et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One. 2014;9(3):e90509. https://doi.org/10.1371/journal.pone.0090509
  6. Lebrun-Frenay C, Kantarci O, Siva A, et al. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event. Ann Neurol. 2020;88(2):407-417.  https://doi.org/10.1002/ana.25799
  7. Kantarci OH, Lebrun C, Siva A, et al. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome. Ann Neurol. 2016;79(2):288-294.  https://doi.org/10.1002/ana.24564
  8. Kantarci O, Siva A, Eraksoy M, et al. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology. 1998;51(3):765-772.  https://doi.org/10.1212/wnl.51.3.765
  9. Okuda DT, Mowry EM, Cree BA, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology. 2011;76(8):686-692.  https://doi.org/10.1212/WNL.0b013e31820d8b1d
  10. Lebrun C, Bensa C, Debouverie M, et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol. 2009;66(7):841-846.  https://doi.org/10.1001/archneurol.2009.119
  11. Villar LM, García-Barragán N, Sádaba MC, et al. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis. J Neurol Sci. 2008;266(1-2):34-37.  https://doi.org/10.1016/j.jns.2007.08.030
  12. Redzic ZB, Segal MB. The structure of the choroid plexus and the physiology of the choroid plexus epithelium. Adv Drug Deliv Rev. 2004;56(12):1695-1716. https://doi.org/10.1016/j.addr.2004.07.005
  13. Wolburg H, Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol. 2010;119(1):75-88.  https://doi.org/10.1007/s00401-009-0627-8
  14. Lorke DE, Kalasz H, Petroianu GA, et al. Entry of oximes into the brain: a review. Curr Med Chem. 2008;15(8):743-753.  https://doi.org/10.2174/092986708783955563
  15. Hutton D, Fadelalla MG, Kanodia AK, et al. Choroid plexus and CSF: an updated review. Br J Neurosurg. 2022;36(3):307-315.  https://doi.org/10.1080/02688697.2021.1903390
  16. Raghib MF, Bao F, Elkhooly M, et al. Choroid plexus volume as a marker of retinal atrophy in relapsing remitting multiple sclerosis. J Neurol Sci. 2024;457:122884. https://doi.org/10.1016/j.jns.2024.122884
  17. Ghersi-Egea JF, Strazielle N, Catala M, et al. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease. Acta Neuropathol. 2018;135(3):337-361.  https://doi.org/10.1007/s00401-018-1807-1
  18. Xu H, Lotfy P, Gelb S, et al. The choroid plexus synergizes with immune cells during neuroinflammation. Cell. 2024;187(18):4946-4963.e17.  https://doi.org/10.1016/j.cell.2024.07.002
  19. Pyka-Fościak G, Lis GJ, Litwin JA. Adhesion Molecule Profile and the Effect of Anti-VLA-4 mAb Treatment in Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis. Int J Mol Sci. 2022;23(9):4637. https://doi.org/10.3390/ijms23094637
  20. Ghersi-Egea JF, Strazielle N, Catala M, et al. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease. Acta Neuropathol. 2018;135(3):337-361.  https://doi.org/10.1007/s00401-018-1807-1
  21. Engelhardt B, Wolburg-Buchholz K, Wolburg H. Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech. 2001;52(1):112-129.  https://doi.org/10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5
  22. Nathanson JA, Chun LL. Immunological function of the blood-cerebrospinal fluid barrier. Proc Natl Acad Sci U S A. 1989;86(5):1684-1688. https://doi.org/10.1073/pnas.86.5.1684
  23. Lassmann H, van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 2012;8(11):647-56.  https://doi.org/10.1038/nrneurol.2012.168
  24. Ricigliano VAG, Louapre C, Poirion E, et al. Imaging Characteristics of Choroid Plexuses in Presymptomatic Multiple Sclerosis: A Retrospective Study. Neurol Neuroimmunol Neuroinflamm. 2022;9(6):e200026. https://doi.org/10.1212/NXI.0000000000200026
  25. Wengler K, Ha J, Syritsyna O, et al. Abnormal blood-brain barrier water exchange in chronic multiple sclerosis lesions: A preliminary study. Magn Reson Imaging. 2020;70:126-133.  https://doi.org/10.1016/j.mri.2020.04.017
  26. Ricigliano VAG, Morena E, Colombi A, et al. Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation. Radiology. 2021;301(1):166-177.  https://doi.org/10.1148/radiol.2021204426
  27. Huang H, Zheng S, Yang Z. Voxel-based morphometry and a deep learning model for the diagnosis of early Alzheimer’s disease based on cerebral gray matter changes. Cereb Cortex. 2023;33(3):754-763.  https://doi.org/10.1093/cercor/bhac099
  28. Potemkina EG, Salomatina TA, Andreev EV, et al. MR morphometry in epileptology: progress and perspectives. Voprosy nejrohirurgii im. N.N. Burdenko. 2023;87(3):113-119. (In Russ.). https://doi.org/10.17116/neiro202387031113
  29. Ågren R, Awad A, Blomstedt P, et al. Voxel-Based Morphometry of Cerebellar Lobules in Essential Tremor. Front Aging Neurosci. 2021;13:667854. https://doi.org/10.3389/fnagi.2021.667854
  30. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage. 2000;11(6 Pt 1):805-21.  https://doi.org/10.1006/nimg.2000.0582
  31. Bergsland N, Dwyer MG, Jakimovski D, et al. Choroid plexus enlargement is associated with future periventricular neurodegeneration in multiple sclerosis. Mult Scler Relat Disord. 2024;87:105668. https://doi.org/10.1016/j.msard.2024.105668
  32. Klistorner S, Barnett MH, Yiannikas C, et al. Expansion of chronic lesions is linked to disease progression in relapsing-remitting multiple sclerosis patients. Mult Scler. 2021;27(10):1533-1542. https://doi.org/10.1177/1352458520974357
  33. Bannai D, Cao Y, Keshavan M, et al. Manual Segmentation of the Human Choroid Plexus Using Brain MRI. J Vis Exp. 2023;(202): 23-28.  https://doi.org/10.3791/65341
  34. Müller J, Sinnecker T, Wendebourg MJ, et al. Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1147. https://doi.org/10.1212/NXI.0000000000001147
  35. Manjón JV, Coupé P. volBrain: An Online MRI Brain Volumetry System. Front Neuroinform. 2016;10:30.  https://doi.org/10.3389/fninf.2016.00030

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.